UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-In Capitol	Accumulated Other Comprehensive Income	Retained Earnings	Total
Balance, value at Dec. 31, 2014	$ 37	$ 2,890	$ (3,234)	$ 64,863	$ 64,556
Balance, shares at Dec. 31, 2014	3,748
Common stock issued upon exercise of employee stock options	$ 0	640			640
Common stock issued upon exercise of employee stock options, shares	22
Common stock received and retired upon exercise of stock options	$ 0	(338)			(338)
Common stock received and retired upon exercise of stock options, shares	(6)
Tax benefit attributable to appreciation of stock options		114			114
Stock option compensation expense		87			87
Common stock purchased and retired	$ 0	(683)			(683)
Common stock purchased and retired, shares	(13)
Foreign currency translation adjustment			(2,724)		(2,724)
Unrealized holding gain (loss) from investments, available-for-sale, net of taxes			(2)		(2)
Common stock dividends				(3,846)	(3,846)
Net income				11,843	11,843
Balance, value at Dec. 31, 2015	$ 38	2,710	(5,961)	72,861	69,648
Balance, shares at Dec. 31, 2015	3,751
Common stock issued upon exercise of employee stock options	$ 0	431			431
Common stock issued upon exercise of employee stock options, shares	13
Common stock received and retired upon exercise of stock options	$ 0	(56)			(56)
Common stock received and retired upon exercise of stock options, shares	(1)
Tax benefit attributable to appreciation of stock options		50			50
Stock option compensation expense		92			92
Common stock purchased and retired	$ (1)	(2,849)			(2,850)
Common stock purchased and retired, shares	(50)
Foreign currency translation adjustment			(6,289)		(6,289)
Unrealized holding gain (loss) from investments, available-for-sale, net of taxes			5		5
Common stock dividends				(3,916)	(3,916)
Net income				12,128	12,128
Balance, value at Dec. 31, 2016	$ 37	378	(12,243)	81,072	69,244
Balance, shares at Dec. 31, 2016	3,713
Common stock issued upon exercise of employee stock options	$ 0	327			327
Common stock issued upon exercise of employee stock options, shares	9
Common stock received and retired upon exercise of stock options	$ 0	(25)			(25)
Common stock received and retired upon exercise of stock options, shares	0
Stock option compensation expense		129			129
Foreign currency translation adjustment			3,893		3,893
Unrealized holding gain (loss) from investments, available-for-sale, net of taxes			10		10
Common stock dividends				(3,960)	(3,960)
Net income				8,505	8,505
Balance, value at Dec. 31, 2017	$ 37	$ 809	$ (8,341)	$ 85,617	$ 78,122
Balance, shares at Dec. 31, 2017	3,721